Why the study?
Sublingual hematoma secondary to warfarin therapy is an extremely rare side effect that can lead to life-threatening complications such as severe airway obstruction.
Sublingual hematoma is a rare but potentially life-threatening bleeding complication of warfarin therapy that can be managed conservatively with early diagnosis and prompt drug discontinuation.
Rare warfarin bleed warrants vigilance for airway compromise; case report leaves incidence and management open.
Warfarin is the most commonly prescribed oral anticoagulant in Nepal. It is commonly used for chronic anticoagulation in patients with atrial fibrillation, venous thromboembolism, and artificial heart valves. The major side effect of warfarin is bleeding. Though extremely rare, a sublingual hematoma can lead to life-threatening complications as it can cause severe airway obstruction. We present a case of a 55-year-old female patient who had sublingual hematoma secondary to the use of Warfarin therapy. In addition to the discontinuation of warfarin, she was managed conservatively without any surgical intervention. Early diagnosis, timely discontinuation of the drug, and application of appropriate medical treatment are of utmost importance for reducing morbidity and mortality due to bleeding and airway compromise.
No takes yet. Share an insight, caveat, or question.
Adhikari et al. (2022) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: